913625-37-3 Usage
Description
(S)-6-benzyloxycarbonylamino-4-(tert-butoxycarbonyl)-4-azaheptan-1-ol is a complex organic compound derived from 4-azaheptan-1-ol, featuring a benzyl group attached to the amino group and a tert-butoxycarbonyl group on the carbon chain. The (S) designation denotes a specific stereochemistry, which may influence its potential applications and properties. This chemical could be relevant in various fields, including organic synthesis and pharmaceutical research, but further investigation is necessary to determine its exact characteristics and uses.
Uses
Used in Organic Synthesis:
(S)-6-benzyloxycarbonylamino-4-(tert-butoxycarbonyl)-4-azaheptan-1-ol is used as an intermediate in organic synthesis for its unique molecular structure and stereochemistry, which can be utilized to create a variety of complex organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (S)-6-benzyloxycarbonylamino-4-(tert-butoxycarbonyl)-4-azaheptan-1-ol is used as a potential building block for the development of new drugs. Its specific stereochemistry and functional groups may contribute to the design of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 913625-37-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,6,2 and 5 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 913625-37:
(8*9)+(7*1)+(6*3)+(5*6)+(4*2)+(3*5)+(2*3)+(1*7)=163
163 % 10 = 3
So 913625-37-3 is a valid CAS Registry Number.
913625-37-3Relevant articles and documents
IOP-lowering effect of isoquinoline-5-sulfonamide compounds in ocular normotensive monkeys
Sumi, Kengo,Inoue, Yoshihiro,Nishio, Masahiro,Naito, Yasuhito,Hosoya, Takamitsu,Suzuki, Masaaki,Hidaka, Hiroyoshi
, p. 831 - 834 (2014/02/14)
Rho-associated coiled coil-formed protein kinase (ROCK) inhibitors are under development as a new class of antiglaucoma agents. Based on the potent ROCK inhibitor H-1152, previously developed by us, we explored the possibility of related compounds as anti
Therapeutic agent for treating glaucoma
-
, (2008/06/13)
The present invention provides compounds useful as therapeutic agent for treating glaucoma and methods for treating glaucoma. That is, a therapeutic agent for treating glaucoma containing, as an active ingredient, a compound represented by formula (1) bel
